Vident Investment Advisory’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $491K | Sell |
|
|||||
|
2023
Q1 | $1.08M | Buy |
|
|||||
|
2022
Q4 | $869K | Buy |
|
|||||
|
2022
Q3 | $763K | Buy |
|
|||||
|
2022
Q2 | $769K | Sell |
|
|||||
|
2022
Q1 | $1.06M | Buy |
|
|||||
|
2021
Q4 | $1.12M | Buy |
|
|||||
|
2021
Q3 | $1.44M | Sell |
|
|||||
|
2021
Q2 | $2.31M | Buy |
|
|||||
|
2021
Q1 | $1.43M | Sell |
|
|||||
|
2020
Q4 | $1.79M | Sell |
|
|||||
|
2020
Q3 | $1.85M | Sell |
|
|||||
|
2020
Q2 | $1.68M | Sell |
|
|||||
|
2020
Q1 | $975K | Sell |
|
|||||
|
2019
Q4 | $1.44M | Sell |
|
|||||
|
2019
Q3 | $1.31M | Sell |
|
|||||
|
2019
Q2 | $1.55M | Buy |
|